Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA to weigh easing limits on unproven peptides BPC 157 Rapid Pro 500mcg Pure Prescriptions The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling